HomeVVOS • NASDAQ
add
Vivos Therapeutics Inc
Previous close
$3.64
Day range
$3.46 - $3.67
Year range
$1.98 - $7.95
Market cap
26.04M USD
Avg Volume
158.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.82M | -5.77% |
Operating expense | 6.98M | 52.06% |
Net income | -5.01M | -159.74% |
Net profit margin | -131.23 | -175.64% |
Earnings per share | -0.55 | 8.33% |
EBITDA | -4.56M | -154.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.40M | -36.23% |
Total assets | 26.03M | 64.33% |
Total liabilities | 21.45M | 125.91% |
Total equity | 4.58M | — |
Shares outstanding | 7.50M | — |
Price to book | 5.78 | — |
Return on assets | -65.19% | — |
Return on capital | -110.72% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.01M | -159.74% |
Cash from operations | -3.49M | -14.63% |
Cash from investing | -5.91M | -9,743.33% |
Cash from financing | 11.46M | 54.86% |
Net change in cash | 2.06M | -52.00% |
Free cash flow | -2.94M | -33.63% |
About
Founded
2016
Headquarters
Website
Employees
113
